(Q54123175)

English

Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report. (English)

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

0 references

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

G Walldius

1

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

L A Carlson

2

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

U Erikson

3

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

A G Olsson

4

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

J Johansson

5

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

J Mölgaard

6

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

S Nilsson

7

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

G Stenport

8

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

L Kaijser

9

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

C Lassvik

10

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

language of work or name

0 references

publication date

1 July 1988

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

American Journal of Cardiology

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

62

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

3

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

37B-43B

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

Prevention of atherosclerotic progression in Watanabe rabbits by probucol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980049-3

7 January 2021

Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980049-3

7 January 2021

In vivo inhibition of foam cell development by probucol in Watanabe rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980049-3

7 January 2021

Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980049-3

7 January 2021

Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980049-3

7 January 2021

Probucol enhances cholesterol efflux from cultured human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980049-3

7 January 2021

Probucol Quantitative Regression Swedish Trial: new angiographic technique to measure atheroma volume of the femoral artery.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980049-3

7 January 2021

Controlled studies of the efficacy and safety of combined probucol-colestipol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980049-3

7 January 2021

Identifiers

10.1016/S0002-9149(88)80049-3

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/3293415

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54123175&oldid=1371353254"